II 

110TH CONGRESS 

1ST SESSION S. 1551 

To amend the Public Health Service Act with respect to making progress 

toward the goal of eliminating tuberculosis, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

JUNE 5, 2007 

Mr. BROWN (for himself, Mrs. HUTCHISON, Mr. KENNEDY, Mrs. CLINTON, 

and Mrs. MURRAY) introduced the following bill; which was read twice 

and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To amend the Public Health Service Act with respect to 

making progress toward the goal of eliminating tuberculosis, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Comprehensive Tuberculosis Elimination Act of 2007’’. 

6 (b) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows: 

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 


hsrobinson on PROD1PC76 with BILLS
2 

•S 1551 IS

TITLE I—CENTERS FOR DISEASE CONTROL AND PREVENTION 

Subtitle A—National Program for Elimination of Tuberculosis 

Sec. 101. National program. 

Subtitle B—Interagency Collaboration 

Sec. 111. Advisory council for elimination of tuberculosis. 

Subtitle C—New Tools for Tuberculosis Elimination 

Sec. 121. New tools. 

Subtitle D—Authorizations of Appropriations 

Sec. 131. Authorizations of appropriations. 

TITLE II—NATIONAL INSTITUTES OF HEALTH 

Sec. 201. Research and development concerning tuberculosis. 

Sec. 202. Activities of National institute of Allergy and Infectious Diseases. 

Sec. 203. John E. Fogarty International Center for Advanced Study in the 

Health Sciences. 

Sec. 204. Loan repayment programs regarding research on tuberculosis. 

Sec. 205. Authorization of appropriations. 

1 SEC. 2. FINDINGS. 

2 The Congress finds as follows: 

3 (1) Each year approximately 9,000,000 people 

4 become ill with active tuberculosis ( referred to in 

5 this section as ‘‘TB’’), and it is estimated that 

6 1,600,000 of those people die, a result of critical 

7 underinvestment in quality TB control and the re8 search and development of new TB drugs, 

9 diagnostics and a vaccine, as well as the comorbid 

10 relationship between TB and HIV/AIDS. Such levels 

11 of morbidity and mortality are complicated by the 

12 disease having the ability to develop resistance to 

13 treatments and to travel easily across borders. 


hsrobinson on PROD1PC76 with BILLS
3 

•S 1551 IS

1 (2) In 2006, there were 13,767 cases of active 

2 TB reported in the United States. The average an3 nual decline in the national TB rate slowed from 7.3 

4 percent per year in the period of 1993 to 2000 to 

5 3.8 percent per year in the period of 2000 to 2006. 

6 (3) In addition to those with active TB, an esti7 mated 10,000,000 to 15,000,000 people in the 

8 United States have latent TB infection. 

9 (4) The increasing occurrence of multidrug re10 sistant (‘‘MDR’’) TB, including extensively drug re11 sistant (‘‘XDR’’) TB—which is resistant to at least 

12 almost all drugs used to treat TB, including the two 

13 recommended first-line drugs and the recommended 

14 second-line medications, raises concerns of a future 

15 epidemic of virtually untreatable TB. 

16 (5) To prevent the spread of extensively drug 

17 resistant TB, the immediate strengthening of TB 

18 control systems must be a priority. This includes im19 proved case detection, strengthened laboratory ca20 pacity, rapid implementation of infection control 

21 measures, enhanced treatment programs, and imme22 diate support to existing public sector infrastructure. 

23 (6) The Centers for Disease Control and Pre24 vention is increasingly relied upon globally for its ex25 pertise and technical assistance in global tuberVerDate Aug 31 2005 22:15 Jun 06, 2007 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S1551.IS S1551

hsrobinson on PROD1PC76 with BILLS
4 

•S 1551 IS

1 culosis preparedness and outbreak response capacity 

2 to identify and investigate outbreaks of multidrug 

3 resistant and extensively drug resistant TB. 

4 (7) New tools are needed to more effectively 

5 prevent, diagnose, and treat TB. The standard 

6 method of diagnosing TB is over 100 years old, and 

7 fails to adequately detect TB, especially in children 

8 and those co-infected with HIV/AIDS. The newest 

9 class of anti-TB drug is over 40 years old, while 

10 rates of multidrug resistant TB are rising globally. 

11 The existing vaccine confers no protection to adoles12 cents and adults, protecting only against severe 

13 forms of TB in infants and young children. 

14 TITLE I—CENTERS FOR DISEASE 

15 CONTROL AND PREVENTION 

16 Subtitle A—National Program for 

17 Elimination of Tuberculosis 

18 SEC. 101. NATIONAL PROGRAM. 

19 Section 317E of the Public Health Service Act (42 

20 U.S.C. 247b–6) is amended— 

21 (1) by striking the heading for the section and 

22 inserting the following: ‘‘NATIONAL PROGRAM FOR

23 ELIMINATION OF TUBERCULOSIS’’; and 

24 (2) by amending subsection (b) to read as fol25 lows: 


hsrobinson on PROD1PC76 with BILLS
5 

•S 1551 IS

1 ‘‘(b) RESEARCH AND DEVELOPMENT; DEMONSTRA2 TION PROJECTS; EDUCATION AND TRAINING.—With re3 spect to the prevention, treatment, control, and elimi4 nation of tuberculosis, the Secretary may, directly or 

5 through grants to public or nonprofit private entities, 

6 carry out the following: 

7 ‘‘(1) Research, with priority given to research 

8 and development concerning— 

9 ‘‘(A) clinical trials to evaluate the safety 

10 and effectiveness of new drugs, diagnostics, and 

11 vaccines for latent tuberculosis infection and ac12 tive tuberculosis, including drug-resistant tuber13 culosis, that are suitable for use by patients 

14 with HIV/AIDS; 

15 ‘‘(B) epidemiological studies of populations 

16 at risk for tuberculosis; and 

17 ‘‘(C) field studies to evaluate the effective18 ness of new drugs, diagnostics, and vaccines, to 

19 assess the incidence and prevalence of 

20 multidrug resistant and extensively drug resist21 ant strains of tuberculosis. 

22 ‘‘(2) Demonstration projects for— 

23 ‘‘(A) the development of regional capabili24 ties to prevent, control and eliminate tuberVerDate Aug 31 2005 22:15 Jun 06, 2007 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S1551.IS S1551

hsrobinson on PROD1PC76 with BILLS
6 

•S 1551 IS

1 culosis and prevent mutidrug resistant and ex2 tensively drug resistant strains of tuberculosis; 

3 ‘‘(B) the intensification of efforts— 

4 ‘‘(i) to prevent, detect, and treat tu5 berculosis among African Americans, His6 panic Americans, Asian Americans, and 

7 other United States-born populations with 

8 documented health disparities; and 

9 ‘‘(ii) to reduce or eliminate racial dis10 parities in the incidence of tuberculosis in 

11 these populations; 

12 ‘‘(C) the intensification of efforts to con13 trol tuberculosis along the United States-Mexico 

14 border and among United States-Mexico bina15 tional populations; 

16 ‘‘(D) the intensification of efforts to pre17 vent, detect, and treat tuberculosis among for18 eign-born persons who are in the United States; 

19 ‘‘(E) providing guidance to Immigration 

20 and Customs Enforcement in developing risk21 based screening procedures based on current 

22 epidemiological data; 

23 ‘‘(F) the intensification of efforts to in24 crease targeted testing and treatment of latent 


hsrobinson on PROD1PC76 with BILLS
7 

•S 1551 IS

1 tuberculosis infection and drug-resistant tuber2 culosis; and 

3 ‘‘(G) the intensification of efforts to pre4 vent, detect, and treat tuberculosis among other 

5 high risk populations and settings, including 

6 among children and adolescents, homeless per7 sons, detainees and prisoners, HIV-infected per8 sons, and within health care settings. 

9 ‘‘(3) A public information and education pro10 gram to include components that raise awareness re11 garding tuberculosis among the general population 

12 as well as those that target populations documented 

13 as having high risk for tuberculosis. 

14 ‘‘(4) Education, training and clinical skills im15 provement activities for health professionals, includ16 ing allied health personnel and emergency response 

17 employees. 

18 ‘‘(5) Provide support for the Tuberculosis 

19 Trials Consortium, the Tuberculosis Epidemiologic 

20 Studies Consortium, the National Laboratory Train21 ing Network, and Regional Training and Medical 

22 Consultation Centers to carry out activities under 

23 paragraphs (1) through (4). 

24 ‘‘(6) Collaboration with international organiza25 tions and foreign countries in intensifying efforts to 


hsrobinson on PROD1PC76 with BILLS
8 

•S 1551 IS

1 prevent, treat, control, and eliminate tuberculosis, 

2 including efforts that address risks associated with 

3 international travel. 

4 ‘‘(7) Develop, enhance, and expand information 

5 technologies that support tuberculosis control, in6 cluding surveillance and database management sys7 tems with cross-jurisdictional capabilities.’’. 

8 Subtitle B—Interagency 

9 Collaboration 

10 SEC. 111. ADVISORY COUNCIL FOR ELIMINATION OF TU11 BERCULOSIS. 

12 (a) IN GENERAL.—Section 317E(f) of the Public 

13 Health Service Act (42 U.S.C. 247b–6(f)) is amended— 

14 (1) by redesignating paragraph (5) as para15 graph (6); and 

16 (2) by striking paragraphs (2) through (4), and 

17 inserting the following: 

18 ‘‘(2) DUTIES.—The Council shall provide advice 

19 and recommendations regarding the elimination of 

20 tuberculosis to the Secretary, the Assistant Sec21 retary for Health, and the Director of the Centers 

22 for Disease Control and Prevention. In addition, the 

23 Council shall, with respect to eliminating such dis24 ease, provide to the Secretary and other appropriate 

25 Federal officials advice on— 


hsrobinson on PROD1PC76 with BILLS
9 

•S 1551 IS

1 ‘‘(A) coordinating the activities of the Pub2 lic Health Service and other Federal agencies 

3 that relate to the disease, including activities 

4 under subsection (b); 

5 ‘‘(B) responding rapidly and effectively to 

6 cases of extensively drug resistant strains of tu7 berculosis; and 

8 ‘‘(C) efficiently utilizing the Federal re9 sources involved. 

10 ‘‘(3) COMPREHENSIVE PLAN.— 

11 ‘‘(A) IN GENERAL.—In carrying out para12 graph (2), the Council shall make recommenda13 tions on the development, revision, and imple14 mentation of a comprehensive plan to eliminate 

15 tuberculosis in the United States. 

16 ‘‘(B) CONSULTATION.—In carrying out 

17 subparagraph (A), the Council shall consult 

18 with public and private entities, including— 

19 ‘‘(i) individuals who are scientists, 

20 physicians, laboratorians, and other health 

21 professionals, who are not officers or em22 ployees of the Federal Government and 

23 who represent the disciplines relevant to 

24 tuberculosis elimination; 


hsrobinson on PROD1PC76 with BILLS
10 

•S 1551 IS

1 ‘‘(ii) members of public-private part2 nerships established to address the elimi3 nation of tuberculosis; 

4 ‘‘(iii) members of national and inter5 national nongovernmental organizations es6 tablished to address tuberculosis elimi7 nation; and 

8 ‘‘(iv) members from the general public 

9 who are knowledgeable with respect to tu10 berculosis elimination including individuals 

11 who have or have had tuberculosis. 

12 ‘‘(C) CERTAIN COMPONENTS OF PLAN.—In 

13 carrying out subparagraph (A), the Council 

14 shall— 

15 ‘‘(i) consider the recommendations of 

16 the Institute of Medicine regarding the 

17 elimination of tuberculosis; 

18 ‘‘(ii) consider recommendations for 

19 the involvement of the United States in 

20 continuing global and cross-border tuber21 culosis control activities in countries where 

22 a high incidence of tuberculosis directly af23 fects the United States such as Mexico; 

24 and 


hsrobinson on PROD1PC76 with BILLS
11 

•S 1551 IS

1 ‘‘(iii) review the extent to which 

2 progress has been made toward eliminating 

3 tuberculosis. 

4 ‘‘(4) ANNUAL REPORT.—The Council shall an5 nually submit to Congress and the Secretary a re6 port on the activities carried under this section, 

7 other than subsection (g). Each such report shall in8 clude the opinion of the Council on the extent to 

9 which its recommendations regarding the elimination 

10 of tuberculosis have been implemented, including 

11 with respect to— 

12 ‘‘(A) activities under subsection (b); and 

13 ‘‘(B) the national plan referred to in para14 graph (3). 

15 ‘‘(5) COMPOSITION.—The Council shall be com16 posed of— 

17 ‘‘(A) representatives from the Centers for 

18 Disease Control and Prevention, the National 

19 Institutes of Health, the United States Agency 

20 for International Development, the Agency for 

21 Healthcare Research and Quality, the Health 

22 Resources and Services Administration, the 

23 United States-Mexico Border Health Commis24 sion, and other Federal departments and agenVerDate Aug 31 2005 22:15 Jun 06, 2007 Jkt 059200 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 E:\BILLS\S1551.IS S1551

hsrobinson on PROD1PC76 with BILLS
12 

•S 1551 IS

1 cies that carry out significant activities related 

2 to tuberculosis; 

3 ‘‘(B) State and local tuberculosis control 

4 and public health officials; 

5 ‘‘(C) individuals who are scientists, physi6 cians, laboratorians, and other health profes7 sionals who represent disciplines relevant to tu8 berculosis elimination; 

9 ‘‘(D) members of national and inter10 national nongovernmental organizations estab11 lished to address the elimination of tuberculosis; 

12 and 

13 ‘‘(E) members from the general public who 

14 are knowledgeable with respect to the elimi15 nation of tuberculosis, including individuals who 

16 have or have had tuberculosis.’’. 

17 (b) RULE OF CONSTRUCTION REGARDING CURRENT

18 MEMBERSHIP.—With respect to the advisory council 

19 under section 317E(f) of the Public Health Service Act, 

20 the amendments made by subsection (a) may not be con21 strued as terminating the membership on such council of 

22 any individual serving as such a member as of the day 

23 before the date of the enactment of this Act. 


hsrobinson on PROD1PC76 with BILLS
13 

•S 1551 IS

1 Subtitle C—New Tools for 

2 Tuberculosis Elimination 

3 SEC. 121. NEW TOOLS. 

4 Section 317E of the Public Health Service Act (42 

5 U.S.C. 247b–6) is amended— 

6 (1) by redesignating subsection (g) as sub7 section (h); and 

8 (2) by inserting after subsection (f) the fol9 lowing subsection: 

10 ‘‘(g) NEW TOOLS FOR ELIMINATION OF TUBER11 CULOSIS.— 

12 ‘‘(1) RESEARCH AND DEVELOPMENT ON DRUGS, 

13 DIAGNOSTICS, VACCINES, AND PUBLIC HEALTH

14 INTERVENTIONS.—The Secretary, acting through 

15 the Director of the Centers for Disease Control and 

16 Prevention, shall expand, intensify, and coordinate 

17 research and development and related activities of 

18 such Centers to develop new tools for the elimination 

19 of tuberculosis, including drugs, diagnostics, vac20 cines, and public health interventions, such as di21 rectly observed therapy and non-pharmaceutical 

22 intervention. 

23 ‘‘(2) FEDERAL TUBERCULOSIS TASK FORCE.— 

24 ‘‘(A) DUTIES.—The Federal Tuberculosis 

25 Task Force (established in December 2001 as 


hsrobinson on PROD1PC76 with BILLS
14 

•S 1551 IS

1 part of the Centers for Disease Control and 

2 Prevention) (in this subsection referred to as 

3 the ‘Task Force’) shall provide to the Secretary 

4 and other appropriate Federal officials advice 

5 on the implementation of paragraph (1), includ6 ing advice regarding the efficient utilization of 

7 the Federal resources involved. 

8 ‘‘(B) COMPREHENSIVE PLAN FOR NEW

9 TOOLS DEVELOPMENT.—In carrying out para10 graph (1), the Task Force shall make rec11 ommendations on the development of a com12 prehensive plan for the creation of new tools for 

13 the elimination of tuberculosis, including drugs, 

14 diagnostics, and vaccines. 

15 ‘‘(C) CONSULTATION.—In developing the 

16 comprehensive plan under paragraph (1), the 

17 Task Force shall consult with— 

18 ‘‘(i) scientists, physicians, 

19 laboratorians, and other health profes20 sionals and who represent the specialties 

21 and disciplines relevant to the research 

22 under consideration; 

23 ‘‘(ii) members from public-private 

24 partnerships or foundations (or both) enVerDate Aug 31 2005 22:15 Jun 06, 2007 Jkt 059200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\S1551.IS S1551

hsrobinson on PROD1PC76 with BILLS
15 

•S 1551 IS

1 gaged in research relevant to research 

2 under consideration; 

3 ‘‘(iii) members of national and inter4 national nongovernmental organizations es5 tablished to address tuberculosis elimi6 nation; 

7 ‘‘(iv) members from the general public 

8 who are knowledgeable with respect to tu9 berculosis, including individuals who have 

10 or have had tuberculosis; and 

11 ‘‘(v) scientists, physicians, 

12 laboratorians, and other health profes13 sionals who reside in a foreign country 

14 with a substantial incidence or prevalence 

15 of tuberculosis, and who represent the spe16 cialties and disciplines relevant to the re17 search under consideration. 

18 ‘‘(3) GRANTS AND CONTRACTS.—The Secretary 

19 shall carry out paragraph (1) directly and through 

20 awards of grants, cooperative agreements, and con21 tracts to public and private entities, including— 

22 ‘‘(A) public-private partnerships; 

23 ‘‘(B) academic institutions, including insti24 tutions of higher education; 

25 ‘‘(C) research institutions; and 


hsrobinson on PROD1PC76 with BILLS
16 

•S 1551 IS

1 ‘‘(D) the Tuberculosis Trials Consortium 

2 and the Tuberculosis Epidemiologic Studies 

3 Consortium.’’. 

4 Subtitle D—Authorizations of 

5 Appropriations 

6 SEC. 131. AUTHORIZATIONS OF APPROPRIATIONS. 

7 Section 317E of the Public Health Service Act, as 

8 amended by section 121(1) of this Act, is amended by 

9 striking subsection (h) and inserting the following: 

10 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.— 

11 ‘‘(1) GENERAL PROGRAM.— 

12 ‘‘(A) IN GENERAL.—For the purpose of 

13 carrying out this section, other than subsections 

14 (b) and (g), there are authorized to be appro15 priated $300,000,000 for fiscal year 2008, and 

16 such sums as may be necessary for each of the 

17 fiscal years 2009 through 2012. 

18 ‘‘(B) RESERVATION FOR EMERGENCY

19 GRANTS.—Of the amounts appropriated under 

20 subparagraph (A) for a fiscal year, the Sec21 retary may reserve not more than 25 percent 

22 for emergency grants under subsection (a) for 

23 any State, political subdivision of a States, or 

24 other public entity in which there is, relative to 

25 other areas, a substantial number of cases of 


hsrobinson on PROD1PC76 with BILLS
17 

•S 1551 IS

1 tuberculosis, multidrug resistant tuberculosis, 

2 or extensively drug resistant tuberculosis or a 

3 substantial rate of increase in such cases. 

4 ‘‘(C) RESEARCH, DEMONSTRATION

5 PROJECTS, EDUCATION, AND TRAINING.—For 

6 the purpose of carrying out subsection (b), 

7 there are authorized to be appropriated such 

8 sums as may be necessary for each of fiscal 

9 years 2008 through 2012. 

10 ‘‘(D) PRIORITY.—In allocating amounts 

11 appropriated under subparagraph (A) and not 

12 reserved under subparagraph (B), the Secretary 

13 shall give priority to allocating such amounts 

14 for grants under subsection (a). 

15 ‘‘(E) ALLOCATION OF FUNDS.— 

16 ‘‘(i) REQUIREMENT OF FORMULA.—Of 

17 the amounts appropriated under subpara18 graph (A), not reserved under subpara19 graph (B), and allocated by the Secretary 

20 for grants under subsection (a), the Sec21 retary shall distribute such amounts to 

22 grantees under subsection (a) on the basis 

23 of a formula. 

24 ‘‘(ii) RELEVANT FACTORS.—The for25 mula developed by the Secretary under 


hsrobinson on PROD1PC76 with BILLS
18 

•S 1551 IS

1 clause (i) shall take into account the level 

2 of tuberculosis morbidity in the respective 

3 geographic area and may consider other 

4 factors relevant to tuberculosis in such 

5 area. 

6 ‘‘(iii) NO CHANGE TO FORMULA RE7 QUIRED.—This subparagraph does not re8 quire the Secretary to modify the formula 

9 that was used by the Secretary to dis10 tribute funds to grantees under subsection 

11 (a) for fiscal year 2007. 

12 ‘‘(2) NEW TOOLS.— 

13 ‘‘(A) IN GENERAL.—For the purpose of 

14 carrying out subsection (g), there are author15 ized to be appropriated $100,000,000 for fiscal 

16 year 2008, and such sums as may be necessary 

17 for each of the fiscal years 2009 through 2012. 

18 ‘‘(B) LIMITATION.—The authorization of 

19 appropriations established in subparagraph (A) 

20 for a fiscal year is effective only if the amount 

21 appropriated under paragraph (1) for such year 

22 equals or exceeds the amount appropriated to 

23 carry out this section for fiscal year 2007.’’. 


hsrobinson on PROD1PC76 with BILLS
19 

•S 1551 IS

1 TITLE II—NATIONAL INSTITUTES 

2 OF HEALTH 

3 SEC. 201. RESEARCH AND DEVELOPMENT CONCERNING TU4 BERCULOSIS. 

5 (a) IN GENERAL.—Subpart 2 of part C of title IV 

6 of the Public Health Service Act (42 U.S.C. 285b et seq.) 

7 is amended by inserting after section 424B the following 

8 section: 

9 ‘‘SEC. 424C. TUBERCULOSIS. 

10 ‘‘(a) IN GENERAL.—The Director of the National In11 stitutes of Health shall expand, intensify, and coordinate 

12 research and development and related activities of the In13 stitute with respect to tuberculosis, including activities to14 ward the goal of eliminating such disease. 

15 ‘‘(b) CERTAIN ACTIVITIES.—Activities under sub16 section (a) shall include— 

17 ‘‘(1) enhancing basic and clinical research on 

18 tuberculosis, including drug resistant tuberculosis; 

19 and 

20 ‘‘(2) expanding research on the relationship be21 tween such disease and the human immunodeficiency 

22 virus.’’. 

23 (b) RESEARCH EDUCATION.—Part A of title IV of 

24 the Public Health Service Act (42 U.S.C. 281 et seq.) is 

25 amended by adding at the end the following: 


hsrobinson on PROD1PC76 with BILLS
20 

•S 1551 IS

1 ‘‘SEC. 404I. TUBERCULOSIS ACADEMIC AWARDS. 

2 ‘‘(a) TUBERCULOSIS ACADEMIC AWARDS.—The Di3 rector of the National Institutes of Health may provide 

4 awards to faculty of schools of medicine, osteopathic medi5 cine, nursing, public health, or related fields to assist such 

6 faculty in developing high quality curricula in such schools 

7 designed to significantly increase the opportunities for in8 terested individuals, including students of the school and 

9 practicing physicians and nurses, to learn the principles 

10 and practices of preventing, managing, and controlling tu11 berculosis. 

12 ‘‘(b) TUBERCULOSIS/PULMONARY INFECTION

13 AWARDS.—The Director of the National Institutes of 

14 Health may provide awards to support the career develop15 ment of clinically trained professionals who are committed 

16 to research regarding pulmonary infections and tuber17 culosis by providing for supervised study and research.’’. 

18 SEC. 202. ACTIVITIES OF NATIONAL INSTITUTE OF AL19 LERGY AND INFECTIOUS DISEASES. 

20 Section 447A of the Public Health Service Act (42 

21 U.S.C. 285f–2) is amended— 

22 (1) by striking ‘‘In carrying out section 446’’ 

23 and inserting ‘‘(a) In carrying out section 446’’; and 

24 (2) by inserting at the end the following: 

25 ‘‘(b) Activities under subsection (a) shall include ac26 tivities to develop a tuberculosis vaccine. Such activities 


hsrobinson on PROD1PC76 with BILLS
21 

•S 1551 IS

1 shall be carried out in accordance with the blueprint for 

2 tuberculosis vaccine development described in the report 

3 prepared pursuant to the workshop convened in March 

4 1998 by the Advisory Council for Elimination of Tuber5 culosis, the Director of the National Vaccine Program, 

6 and the Director of the Institute.’’. 

7 SEC. 203. JOHN E. FOGARTY INTERNATIONAL CENTER FOR 

8 ADVANCED STUDY IN THE HEALTH 

9 SCIENCES. 

10 Section 482 of the Public Health Service Act (42 

11 U.S.C. 287b) is amended— 

12 (1) by inserting ‘‘(a) IN GENERAL.—’’ before 

13 ‘‘The general purpose’’; 

14 (2) in subsection (a) (as so designated), by in15 serting after ‘‘Health Sciences’’ the following: ‘‘(in 

16 this subpart referred to as the ‘Center’)’’; and 

17 (3) by adding at the end the following sub18 section: 

19 ‘‘(b) TUBERCULOSIS.— 

20 ‘‘(1) IN GENERAL.—In carrying out subsection 

21 (a) with respect to tuberculosis, the Center shall ex22 pand, intensify, and coordinate international activi23 ties of the Center for research and training. 

24 ‘‘(2) INTERNATIONAL TRAINING PROGRAM.—In 

25 carrying out paragraph (1), the Center shall carry 


hsrobinson on PROD1PC76 with BILLS
22 

•S 1551 IS

1 out an international training program regarding tu2 berculosis. Such program shall be modeled after the 

3 international training program carried out by the 

4 Center with respect to the human immunodeficiency 

5 virus.’’. 

6 SEC. 204. LOAN REPAYMENT PROGRAMS REGARDING RE7 SEARCH ON TUBERCULOSIS. 

8 Part G of title IV of the Public Health Service Act 

9 (42 U.S.C. 288 et seq.) is amended— 

10 (1) by redesignating the second section 487F as 

11 section 487G; and 

12 (2) by inserting after section 487G (as so re13 designated) the following section: 

14 ‘‘LOAN REPAYMENTS REGARDING RESEARCH ON

15 TUBERCULOSIS

16 ‘‘SEC. 487H. In carrying out sections 487C, 487E, 

17 and 487F, the Secretary shall seek to ensure that, for fis18 cal year 2008 and subsequent fiscal years, a portion of 

19 amounts appropriated to carry out such sections is re20 served for the purpose of entering into contracts under 

21 which (in accordance with the section involved) individuals 

22 will conduct research on tuberculosis. The Secretary shall 

23 have sole discretion for the administration of activities 

24 under this section.’’. 


hsrobinson on PROD1PC76 with BILLS
23 

•S 1551 IS

1 SEC. 205. AUTHORIZATION OF APPROPRIATIONS. 

2 For the purpose of carrying out this title and the 

3 amendments made by this title, there are authorized to 

4 be appropriated such sums as may be necessary. Such au5 thorization of appropriations shall be in addition to the 

6 authorization of appropriations established by section 

7 402A(a) of the Public Health Service Act and any other 

8 authorization of appropriations available for such purpose. 

Æ 


hsrobinson on PROD1PC76 with BILLS